Bioactivity:

Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory, immunomodulating and antineoplastic activities.

CAS nr:

1187594-09-7

Purity:

98%

Molecular Weight:

371,42

SMILES:

CCS(=O)(=O)N1CC(C1)(CC#N)n1cc(cn1)c1c2cc[nH]c2ncn1

Formula:

C16H17N7O2S

Pathway:

Stem Cells,Angiogenesis,JAK/STAT signaling,Chromatin/Epigenetic,Tyrosine Kinase/Adaptors,Cell Cycle/Checkpoint

Target:

JAK,JAK,JAK,JAK,Tyrosine Kinases,Chk